학술논문
Fluoxetine a Selective Serotonin Uptake Inhibitor for the Treatment of Outpatients with Major Depression
Document Type
Article
Source
Journal of Clinical Psychopharmacology; April 1988, Vol. 8 Issue: 2 p112-115, 4p
Subject
Language
ISSN
02710749; 1533712X
Abstract
In a double-blind, placebo-controlled study the authors found that fluoxetine, a potent and selective inhibitor of serotonin reuptake, was an effective antidepressant in moderately depressed, ambulatory outpatients. Typical adverse effects reported by patients treated with fluoxetine included agitation, nausea, fatigue, and insomnia. Compared to imipramine, fluoxetine was associated with fewer complaints of dry mouth, constipation, and dizziness.